Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial - Top-Institutions - MDSpire

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial

  • By

  • Peter S. Hendricks

  • Sara N. Lappan

  • Richard C. Shelton

  • Adrienne C. Lahti

  • Karen L. Cropsey

  • Matthew W. Johnson

  • Melissa Bradley

  • Otto Simonsson

  • Lori L. Davis

  • Daniel H. Grossman

  • Cynthia E. Ortiz

  • May 7, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    University of Alabama at Birmingham
    University of Alabama at Birmingham

    Birmingham, AL

    Key Differentiators

    • Psychiatry

  • #2

    Johns Hopkins Bayview Medical Center
    Johns Hopkins Bayview Medical Center

    Baltimore, MD

    Key Differentiators

    • Psychiatry

Original Source(s)

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial

  • by Peter S. Hendricks, Sara N. Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson, Melissa Bradley, Otto Simonsson, Lori L. Davis, Daniel H. Grossman, Cynthia E. Ortiz

  • May 7, 2026

Related Content

6 takeaways from STAT’s investigation into the U.S. alcohol epidemic

Hospital-Based Management of Opioid Use Disorder in the Fentanyl Era—The Role and Limits of Expert Consensus

Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization